The Impact of the Microbiome on Cancer Progression and Therapy
The Sixth Annual Microbiome Symposium offers both a lecture, open to the public, and a conference for the scientific community.
- Wednesday, October 2, 2019: Lecture (open to the public)
- Thursday, October 3, 2019: Symposium (research community)
- Registration, location, and contact information COMING SOON!
– Thursday, Oct. 3 Academic Symposium –
"The Secrets of Intestinal Microbiota for Oncoimmunologists"
Laurence Zitvogel, MD, PhD
- "The Fiber-Microbiota-Butyrate Axis in Tumor Suppression"
Scott Bultman, PhD
- "Tumors Remotely Control Gut Microbiota and Suppress Cancer Immune Response"
Andrea Facciabene, PhD
- "Commensal Microbiota and Anti-Tumor Immunity"
Thomas Gajewski, MD, PhD
- "Immune-Microbiota Interaction in Lung Cancer"
Chengcheng Jin, PhD
- "Molecular Control of the Gut Microbiota to Improve Therapeutic Outcomes"
Matthew Redinbo, PhD
- "Human Microbiome and Cancer"
- Rashmi Sinha, PhD
- "Microbiome and Diet in Cancer Therapy"
Giorgio Trinchieri, MD
- "The Role of the Intestinal Microbiome in Allogenic Stem Cell Transplantation"
Marcel van den Brink, MD, PhD
Co-organized by Penn Medicine Abramson Cancer Center, the Children’s Hospital of Philadelphia Microbiome Program, Penn Vet Center for Host-Microbial Interactions, and the Penn Vet Cancer Center.